Literature DB >> 3599185

Functional differences in the peplomer glycoproteins of feline coronavirus isolates.

S A Fiscus, Y A Teramoto.   

Abstract

The feline coronaviruses can be divided into two distinct antigenic groups on the basis of antigenic differences found on the peplomer (E2) glycoprotein of the virus. Because the E2 glycoprotein is responsible for many of the biological functions of coronaviruses, experiments were done to determine whether there were any E2 functional differences between these two antigenic groups. The avirulent feline infectious peritonitis virus (FIPV) isolate FIPV-UCD-2, which has one antigenic type of E2, was less rapidly internalized and could not spread from cell to cell in the presence of neutralizing antibody. Two virulent isolates, FIPV-DF2 and FIPV-79-1146, as well as the non-FIP-causing feline enteric coronavirus (FECV) isolate FECV-79-1683, all of which have the second antigenic type of E2, were very rapidly internalized and were able to spread from cell to cell despite the presence of neutralizing antibody. The avirulent FIPV-UCD-2 and FECV-79-1683 isolates were more labile at 37 degrees C at pHs of 6.5 and above than were the virulent FIPV-DF2 and FIPV-79-1146 isolates.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3599185      PMCID: PMC255718     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  10 in total

1.  Recovery and in vitro cultivation of a coronavirus from laboratory-induced cases of feline infectious peritonitis (FIP).

Authors:  J W Black
Journal:  Vet Med Small Anim Clin       Date:  1980-05

2.  Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

Authors:  J O Fleming; M D Trousdale; F A el-Zaatari; S A Stohlman; L P Weiner
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Characterization of a feline infectious peritonitis virus isolate.

Authors:  J F Evermann; L Baumgartener; R L Ott; E V Davis; A J McKeirnan
Journal:  Vet Pathol       Date:  1981-03       Impact factor: 2.221

4.  The structure and behavior of coronavirus A59 glycoproteins.

Authors:  L S Sturman
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

5.  Feline infectious peritonitis: isolation of a coronavirus.

Authors:  K J O'Reilly; B Fishman; L M Hitchcock
Journal:  Vet Rec       Date:  1979-04-14       Impact factor: 2.695

6.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence.

Authors:  R G Dalziel; P W Lampert; P J Talbot; M J Buchmeier
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins.

Authors:  S A Fiscus; Y A Teramoto
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

8.  Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody.

Authors:  M J Buchmeier; H A Lewicki; P J Talbot; R L Knobler
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

9.  An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis.

Authors:  N C Pedersen; J F Boyle; K Floyd; A Fudge; J Barker
Journal:  Am J Vet Res       Date:  1981-03       Impact factor: 1.156

Review 10.  The molecular biology of coronaviruses.

Authors:  L S Sturman; K V Holmes
Journal:  Adv Virus Res       Date:  1983       Impact factor: 9.937

  10 in total
  10 in total

1.  Prevalence and implications of feline coronavirus infections of captive and free-ranging cheetahs (Acinonyx jubatus).

Authors:  J L Heeney; J F Evermann; A J McKeirnan; L Marker-Kraus; M E Roelke; M Bush; D E Wildt; D G Meltzer; L Colly; J Lukas
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Intrinsic resistance of feline peritoneal macrophages to coronavirus infection correlates with in vivo virulence.

Authors:  C A Stoddart; F W Scott
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Biological and pathological consequences of feline infectious peritonitis virus infection in the cheetah.

Authors:  J F Evermann; J L Heeney; M E Roelke; A J McKeirnan; S J O'Brien
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 4.  Perspectives on the epizootiology of feline enteric coronavirus and the pathogenesis of feline infectious peritonitis.

Authors:  J F Evermann; A J McKeirnan; R L Ott
Journal:  Vet Microbiol       Date:  1991-08-15       Impact factor: 3.293

5.  Antigenic and biological diversity among transmissible gastroenteritis virus isolates of swine.

Authors:  E M Vaughn; P S Paul
Journal:  Vet Microbiol       Date:  1993-09       Impact factor: 3.293

6.  Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis.

Authors:  Viviane Benetka; Anna Kübber-Heiss; Jolanta Kolodziejek; Norbert Nowotny; Margarete Hofmann-Parisot; Karin Möstl
Journal:  Vet Microbiol       Date:  2004-03-26       Impact factor: 3.293

7.  Fatal enteritis associated with coronavirus infection in cats.

Authors:  A Kipar; J Kremendahl; D D Addie; W Leukert; C K Grant; M Reinacher
Journal:  J Comp Pathol       Date:  1998-07       Impact factor: 1.311

Review 8.  A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination.

Authors:  C W Olsen
Journal:  Vet Microbiol       Date:  1993-07       Impact factor: 3.293

9.  Prevalence of feline coronavirus in two cat populations in Malaysia.

Authors:  Saeed Sharif; Siti S Arshad; Mohd Hair-Bejo; Abdul R Omar; Nazariah A Zeenathul; Mohd A Hafidz
Journal:  J Feline Med Surg       Date:  2009-10-08       Impact factor: 2.015

10.  Molecular cloning and sequence determination of the peplomer protein gene of feline infectious peritonitis virus type I.

Authors:  K Motokawa; T Hohdatsu; C Aizawa; H Koyama; H Hashimoto
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.